AuXin Surgery SA

?
The CADISS® System is a novel line of medical devices for the selective dissection of pathological tissues and fibrosis. The system is able to facilitate many surgical procedures while preserving critical organs such as nerves, muscles or vessels.

?
CADISS® is a method of selective dissection based on the combination of irrigated mechanical dissectors with the topical application of a solution of the drug Mesna.
The CADISS® System is not intended to replace existing dissection systems but rather to supplement them in those tissue dissection steps where :
➡ Conventional mechanical dissection is difficult due to the adherence between the tissues.
➡ Risks of side effects from non-selective cutting instruments such as electric or laser knives are significant.

? ✔
Conclusive tests in 7 indications with results published on about 1000 patients.
The CADISS® System is CE-mark in class III for EAR and Musculoskeletal surgery.
Additional clinical trials are on-going to support extension to additional surgery indications. ‍

?
➕ Reduce surgery side effects
➕ Reduce relapses
➕ Saving time
➕ Facilitating procedures

AuXin Surgery manages multiple key activities including product development, supply chain, and global marketing strategies whereas local activities are partnered.

AuXin Surgery currently distributes its device on 4 continents (32 countries) and is ready to rapidly expand to other countries and continents.

www.auxin.eu

Company’s Keywords:

medical devices, surgery, product development, supply chain, international marketing